Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 24, 2023
October 1, 2024
fc84d5fe-2f95-4d3c-9001-406c9aa4ef09
Related Documents
Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers
Guidance DocumentDecember 27, 2021Center for Drug Evaluation and Research
A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers: Guidance for Industry
Guidance DocumentApril 12, 2023Center for Drug Evaluation and Research
Use of Electronic Informed Consent in Clinical Investigations – Questions and Answers: Guidance for Institutional Review Boards, Investigators, and Sponsors
Guidance DocumentDecember 15, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox